Randolph C. Steer, MD, PhD is the former
President Capstone Therapeutics.. Dr. Steer has
been an independent pharmaceutical, biotechnology
and medical devices consultant since 1989, and has provided
consulting services to Capstone since 2002.
He has served as Associate Director of Medical Affairs at Marion Laboratories; Medical Director at Ciba Consumer Pharmaceuticals (Ciba-Geigy Corporation); Vice President, Senior Vice President and Member of the Executive Committee at Physicians World Communications Group; Chairman, President and Chief Executive Officer of AdvancedTherapeutics Communications International, a global drug regulatory group, and Chairman and Chief Executive Officer of Vicus.com, Inc. He is a member of the Board of Directors of Techne Corporation and BioCryst Pharmaceuticals. Dr. Steer received his MD degree from the Mayo Medical School and his PhD from the University of Minnesota, where he also completed a residency and subspecialty fellowship in clinical and chemical pathology. He is a Fellow of the American College of Clinical Pharmacology.
President Capstone Therapeutics.. Dr. Steer has
been an independent pharmaceutical, biotechnology
and medical devices consultant since 1989, and has provided
consulting services to Capstone since 2002.
He has served as Associate Director of Medical Affairs at Marion Laboratories; Medical Director at Ciba Consumer Pharmaceuticals (Ciba-Geigy Corporation); Vice President, Senior Vice President and Member of the Executive Committee at Physicians World Communications Group; Chairman, President and Chief Executive Officer of AdvancedTherapeutics Communications International, a global drug regulatory group, and Chairman and Chief Executive Officer of Vicus.com, Inc. He is a member of the Board of Directors of Techne Corporation and BioCryst Pharmaceuticals. Dr. Steer received his MD degree from the Mayo Medical School and his PhD from the University of Minnesota, where he also completed a residency and subspecialty fellowship in clinical and chemical pathology. He is a Fellow of the American College of Clinical Pharmacology.
Randolph C. Steer. M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
Reconstituting the Reverse
Cholesterol Transport Pathway
LipimetiX Development, LLC.